{"id":"W4414708467","doi":"10.1016/s2213-8587(25)00216-5","title":"Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Inversago Pharma (Canada); Université Laval","funders":"National Institutes of Health; Novo Nordisk","keywords":"Obesity; MEDLINE; Phase (matter); Clinical trial; Diabetes mellitus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002021541,0.00292705,0.005110734,0.0005479677,0.0007460645,0.001774001,0.001161313,0.003389927,0.009497773],"category_scores_gemma":[0.002853485,0.001257096,0.003007741,0.0004817806,0.001732366,0.002105029,0.0005914422,0.004631065,0.001996056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000826753,"about_ca_system_score_gemma":0.0009669961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009094666,"about_ca_topic_score_gemma":0.001798865,"domain_scores_codex":[0.9992525,0.0003050983,0.00006793597,0.0001895217,0.00006363833,0.0001213416],"domain_scores_gemma":[0.9990897,0.0002611671,0.0002251442,0.00009007679,0.00007212743,0.0002617221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9890339,0.001680717,0.0002019005,0.0007403258,0.001020372,0.0000309198,0.00003971541,0.00007578962,0.001590991,0.00006892213,0.0005160058,0.00500047],"study_design_scores_gemma":[0.9824991,0.01531858,0.0007792866,0.00003639579,0.0005509465,0.00002923921,0.00001898318,0.0001237271,0.0001745461,0.0001021204,0.0003509976,0.00001614711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9657386,0.01785774,0.001565324,0.001916559,0.001931109,0.0045288,0.002414926,0.0003552768,0.003691754],"genre_scores_gemma":[0.9746516,0.008137764,0.002222779,0.002382151,0.0009499704,0.004839489,0.001778629,0.0000778397,0.004959798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009497773,"threshold_uncertainty_score":0.03177315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01761303373829149,"score_gpt":0.3119015161514564,"score_spread":0.294288482413165,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}